M
Medial Earlysign
Healthcare company using AI to predict and prevent high-risk diseases
About Medial Earlysign
Medial EarlySign, founded in 2009 by machine learning pioneers, specializes in analyzing clinical data to detect early signs of serious diseases such as cancer. The company collaborates with leading health systems in the United States, Europe, and Asia, leveraging a wide array of clinical data including claims and advanced diagnostics. Medial EarlySign's technology organizes and analyzes clinical data using machine learning and artificial intelligence, transforming it into actionable clinical insights. The company serves a diverse range of clients including healthcare providers, labs, payers, diagnostics, pharma, and life sciences sectors. Operating in the healthcare market, Medial EarlySign's business model focuses on providing advanced data analytics solutions to improve early disease detection and patient outcomes. Revenue is generated through partnerships and service agreements with healthcare organizations.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Kfar Malal, Israel
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 62.8/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Intellectual Property, Risk Management, Data Analytics, Predictive Analytics, Biotechnology, Oncology, Drug Development, Clinical, Core AI, Precision Medicine, Tech for Hospitals and Clinics
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Mar 2018 | $30M | $120M | Marius Nacht · Horizons Ventures · Nir Kalkstein · aMoon Fund | ↗ |
| SERIES AOther financing | Jun 2013 | $20M | $80M | Horizon Ventures | — |
Growth signals
Latest recorded traffic for Medial Earlysign is 100 monthly website visits, down 47.4% over the last three months. Medial Earlysign's team declined 20% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Horizon Ventures
aMoon Fund
Marius Nacht
Horizons Ventures
Nir Kalkstein
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medial Earlysign on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medial Earlysign’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.